Home >> Law >> Food & Beverage >>

Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015

Published: May-2015 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 19832

Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015’, provides an overview of the Enceladus Pharmaceuticals BV’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Enceladus Pharmaceuticals BV’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Enceladus Pharmaceuticals BV including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Enceladus Pharmaceuticals BV’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Enceladus Pharmaceuticals BV’s pipeline products

Reasons to buy

- Evaluate Enceladus Pharmaceuticals BV’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Enceladus Pharmaceuticals BV in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Enceladus Pharmaceuticals BV’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Enceladus Pharmaceuticals BV and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Enceladus Pharmaceuticals BV
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Enceladus Pharmaceuticals BV and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Enceladus Pharmaceuticals BV Snapshot 4
Enceladus Pharmaceuticals BV Overview 4
Key Information 4
Key Facts 4
Enceladus Pharmaceuticals BV - Research and Development Overview 5
Key Therapeutic Areas 5
Enceladus Pharmaceuticals BV - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Enceladus Pharmaceuticals BV - Pipeline Products Glance 9
Enceladus Pharmaceuticals BV - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Enceladus Pharmaceuticals BV - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Enceladus Pharmaceuticals BV - Drug Profiles 13
prednisolone sodium phosphate liposomal 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
dexamethasone acetate liposomal 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Corticosteroid liposimal 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Enceladus Pharmaceuticals BV - Pipeline Analysis 17
Enceladus Pharmaceuticals BV - Pipeline Products by Target 17
Enceladus Pharmaceuticals BV - Pipeline Products by Route of Administration 18
Enceladus Pharmaceuticals BV - Pipeline Products by Molecule Type 19
Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action 20
Enceladus Pharmaceuticals BV - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables
Enceladus Pharmaceuticals BV, Key Information 4
Enceladus Pharmaceuticals BV, Key Facts 4
Enceladus Pharmaceuticals BV - Pipeline by Indication, 2015 6
Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015 7
Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015 8
Enceladus Pharmaceuticals BV - Phase II, 2015 9
Enceladus Pharmaceuticals BV - Phase I, 2015 10
Enceladus Pharmaceuticals BV - Preclinical, 2015 11
Enceladus Pharmaceuticals BV - Discovery, 2015 12
Enceladus Pharmaceuticals BV - Pipeline by Target, 2015 17
Enceladus Pharmaceuticals BV - Pipeline by Route of Administration, 2015 18
Enceladus Pharmaceuticals BV - Pipeline by Molecule Type, 2015 19
Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action, 2015 20

List of Figures
Enceladus Pharmaceuticals BV - Pipeline by Top 10 Indication, 2015 6
Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015 7
Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015 8
Enceladus Pharmaceuticals BV - Pipeline by Top 10 Target, 2015 17
Enceladus Pharmaceuticals BV - Pipeline by Top 10 Route of Administration, 2015 18
Enceladus Pharmaceuticals BV - Pipeline by Top 10 Molecule Type, 2015 19
Enceladus Pharmaceuticals BV - Pipeline Products by Top 10 Mechanism of Action, 2015 20

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing